Study of a Flu Vaccine in Children
Launched by NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID) · Aug 30, 2001
Current as of November 28, 2023
This is a Phase III trial (an advanced study with a large number of patients). Your child will receive a single dose of flu vaccine, which is given by a nasal spray.
- Inclusion Criteria:
- Your child may be eligible for this study if he/she:
- Is between the ages of 18 months and 18 years, with consent of parent or guardian.
- Is a resident of the Temple-Belton, Texas area.
- Exclusion Criteria:
- Your child will not be eligible for this study if he/she:
- Has had a fever within 3 days before vaccination.
- Has symptoms of a weakened immune system.
- Has had a wheezing episode within the past 2 weeks.
- Has moderate to severe asthma.
- Is allergic to eggs.
- Needs to take aspirin on a regular basis.
- Has received another vaccine or study drug in the past month.
The National Institute of Allergy and Infectious Diseases (NIAID, /ˈnaɪ.æd/) is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Houston, Texas, United States
All reviews come from applied patients